Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Aspirin Use Tied to Slower AAA Progression

News Daily News

Aspirin Use Tied to Slower AAA Progression

December 20, 2023

JACC Statement Focuses on PAD Disparities, Gaps in Care

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

December 04, 2023

High-Sensitivity Troponins May Overestimate PE Severity

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

November 28, 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

October 25, 2023

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

July 11, 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

News Conference News ESOC 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

June 02, 2023

OPTIMAL-BP Shows Harm of Too Much BP-Lowering After Stroke Thrombectomy

News Conference News ESOC 2023

OPTIMAL-BP Shows Harm of Too Much BP-Lowering After Stroke Thrombectomy

June 01, 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

News Conference News ESOC 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

May 26, 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

May 25, 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

May 24, 2023

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

January 24, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.